Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects

Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial

(2016) Hong Sun et al.   LANCET NEUROLOGY

Characterizing the PK/PD relationship for inhibition of capsaicin-induced dermal vasodilatation by MK-3207, an oral calcitonin gene related peptide receptor antagonist

(2015) Chi-Chung Li et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Development of anti-migraine therapeutics using the capsaicin-induced dermal blood flow model

(2015) Linde Buntinx et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Theoretical Considerations of Target-Mediated Drug Disposition Models: Simplifications and Approximations

(2011) Peiming Ma   PHARMACEUTICAL RESEARCH

Population Pharmacokinetics of Therapeutic Monoclonal Antibodies

(2010) Nathanael L. Dirks et al.   CLINICAL PHARMACOKINETICS

The Epidemiology of Primary Headache Disorders

(2010) Matthew Robbins et al.   SEMINARS IN NEUROLOGY

Biodistribution Mechanisms of Therapeutic Monoclonal Antibodies in Health and Disease

(2009) Mohammad Tabrizi et al.   AAPS Journal

Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974)

(2009) Simon R. Sinclair et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Monoclonal Antibody Pharmacokinetics and Pharmacodynamics

(2008) W Wang et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Approximations of the target-mediated drug disposition model and identifiability of model parameters

(2008) Leonid Gibiansky et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Calcitonin Gene-Related Peptide8-37 Antagonizes Capsaicin-Induced Vasodilation in the Skin: Evaluation of a Human in Vivo Pharmacodynamic Model

(2008) B. J. Van der Schueren et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS